Insider Buying: Starpharma Holdings Limited (ASX:SPL) Insider Purchases 879,687 Shares of Stock

Starpharma Holdings Limited (ASX:SPL) insider Jeff Davies bought 879,687 shares of the business’s stock in a transaction on Friday, June 28th. The shares were acquired at an average price of A$0.09 ($0.06) per share, with a total value of A$80,051.52 ($53,367.68).

Starpharma Stock Performance

The company has a quick ratio of 5.65, a current ratio of 5.60 and a debt-to-equity ratio of 9.08.

Starpharma Company Profile

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.